Percutaneous Placement of Peritoneal Port-Catheter in Patients with Malignant Ascites

  • Orhan Ozkan
  • Devrim Akinci
  • Rahsan Gocmen
  • Barbaros Cil
  • Mustafa Ozmen
  • Okan Akhan


We report our experience with a radiologically placed peritoneal port-catheter in palliation of malignant ascites. Port-catheters were successfully placed under ultrasonographic and fluoroscopic guidance in seven patients (five women, two men) who had symptomatic malignant ascites. The long-term primary patency rate was 100%. The mean duration of catheter function was 148 days. Seven patients had a total of 1040 port-days. Two patients received intraperitoneal chemotherapy via the port-catheter. There were no procedure-related mortality and major complications. Minor complications such as ascitic fluid leakage from the peritoneal entry site, migration of the catheter tip to the right upper quadrant, and reversal of the port reservoir occurred in four patients. None of these complications affected the drainage and required port explantation. In patients with symptomatic malignant ascites, a peritoneal port-catheter can provide palliation and eliminate multiple hospital visits for repeated paracentesis with high patency and low complication rates.


Malignant ascites Peritoneal port 


  1. 1.
    Lacy JH, Wieman TJ, Shively EH (1984) Management of malignant ascites. Surg Obstet Gynecol 159:397–412Google Scholar
  2. 2.
    O’Neill MJ, Weissleder R, Gervais DA, et al. (2001) Tunneled peritoneal catheter placement under sonographic and fluoroscopic guidance in the palliative treatment of malignant ascites. Am J Roentgenol 177:615–618Google Scholar
  3. 3.
    Rosenblum DI, Geisinger MA, Newman JS, et al. (2001) Use of subcutaneous venous access ports to treat refractory ascites. J Vasc Intervent Radiol 12:1343–1346Google Scholar
  4. 4.
    Savin MA, Kirsch MJ, Romano WJ, et al. (2005) Peritoneal ports for treatment of intractable ascites. J Vasc Intervent Radiol 16:363–368Google Scholar
  5. 5.
    Park JS, Won JY, Park SI, et al. (2001) Percutaneous peritoneovenous shunt creation for the treatment of benign and malignant refractory ascites. J Vasc Intervent Radiol 12:1445–1448Google Scholar
  6. 6.
    Orsi F, Vigna PD, Penco S, et al. (2004) Percutaneous placement of peritoneal port-catheter in oncologic patients. Eur Radiol 14:2020–2024PubMedCrossRefGoogle Scholar
  7. 7.
    Lorentzen T, Sengelov L, Nolsoe CP, et al. (1995) Ultrasonographically guided insertion of a peritoneo-gastric shunt in patients with malignant ascites. Acta Radiol 36:481–484PubMedCrossRefGoogle Scholar
  8. 8.
    Rozenblit GN, Del Guercio LRM, Rundback JH, et al. (1998) Peritoneal-urinary drainage for treatment of refractory ascites: A pilot study. J Vasc Intervent Radiol 9:998–1005CrossRefGoogle Scholar
  9. 9.
    Hussain FF, Meer ZF, Lopez AJ (2004) Peritoneovenous shunt insertion for intractable ascites: A district general hospital experience. Cardiovasc Intervent Radiol 27:325–328PubMedCrossRefGoogle Scholar
  10. 10.
    Richard HM, Coldwell DM, Boyd-Kranis RL, et al. (2001) Pleurx tunneled catheter in the management of malignant ascites. J Vasc Intervent Radiol 12:373–375Google Scholar
  11. 11.
    Sabatelli FW, Glassman ML, Kerns SR, et al. (1994) Permanent indwelling peritoneal access device for the management of malignant ascites. Cardiovasc Intervent Radiol 17:292–294PubMedCrossRefGoogle Scholar
  12. 12.
    Moskovitz M (1990) The peritoneovenous shunt: expectations and reality. Am J Gastroenterol 85:917–929PubMedGoogle Scholar
  13. 13.
    Gough IR, Balderson GA (1993) Malignant ascites: A comparison of peritonevenous shunting and nonoperative management. Cancer 7:2377–2382CrossRefGoogle Scholar
  14. 14.
    Barnett TD, Rubins J (2002) Placemet of a permanent tunneled peritoneal drainage catheter for palliation of malignant asciites: A simplified percutaneous approach. J Vasc Intervent Radiol 13:379–383Google Scholar
  15. 15.
    Sartori S, Nielsen I, Trevisani L, et al. (2002) Sonographically guided peritoneal catheter placement in the palliation of malignant ascites in end-stage malignancies. Am J Roentgenol 179:1618–1620Google Scholar
  16. 16.
    Kurtz RC, Bronzo RL (1982) Does spontaneous bacterial peritonitis occur in malignant ascites? Am J Gastroenterol 77:146–148PubMedGoogle Scholar
  17. 17.
    Markman M (1986) Intraperitoneal antineoplastic agents for tumors principally confined to the peritoneal cavity. Cancer Treat Rev 13:219–242 PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, Inc. 2007

Authors and Affiliations

  • Orhan Ozkan
    • 1
  • Devrim Akinci
    • 1
  • Rahsan Gocmen
    • 1
  • Barbaros Cil
    • 1
  • Mustafa Ozmen
    • 1
  • Okan Akhan
    • 1
  1. 1.Department of RadiologyHacettepe University School of MedicineSihhiyeTurkey

Personalised recommendations